Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR)
| Autor: | Zehentmayr, Franz, Feurstein, Petra, Ruznic, Elvis, Langer, Brigitte, Grambozov, Brane, Klebermass, Marisa, Hüpfel, Herbert, Feichtinger, Johann, Minasch, Danijela, Heilmann, Martin, Breitfelder, Barbara, Steffal, Claudia, Gastinger-Grass, Gisela, Kirchhammer, Karoline, Kazil, Margit, Stranzl, Heidi, Dieckmann, Karin |
|---|---|
| Zdroj: | In Radiotherapy and Oncology July 2024 196 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect